GROVE SURGERY — All Prescriptions & Medications — Page 12
Practice Code: D82002 | THETFORD, IP24 2HY
Showing results 551-600 of 600
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Mometasone/glycopyrronium/indacaterol | 13 | 390 | £550 | -14.2% ▼ |
| Nitrazepam | 13 | 728 | £37 | -75.0% ▼ |
| Pivmecillinam hydrochloride | 13 | 216 | £112 | -75.2% ▼ |
| Dapsone | 13 | 403 | £98 | +25.8% ▲ |
| Oestrogens conjugated with progestogen | 13 | 1,036 | £400 | +82.4% ▲ |
| Fesoterodine fumarate | 13 | 364 | £31 | -67.0% ▼ |
| Cinacalcet hydrochloride | 13 | 364 | £94 | -44.0% ▼ |
| Tube feed 1.5 kcal/ml peptide based (0914032) | 13 | 364.0K | £8.6K | +35.6% ▲ |
| 13 | 25 | £221 | +9.2% ▲ | |
| Zinc oxide | 12 | 364 | £43 | -42.0% ▼ |
| Losartan potassium with diuretic | 12 | 336 | £39 | -53.2% ▼ |
| Doxepin | 12 | 1,288 | £3.3K | -7.7% ▼ |
| Reboxetine | 12 | 1,008 | £303 | -22.1% ▼ |
| Empagliflozin/metformin | 12 | 672 | £417 | -77.0% ▼ |
| Empagliflozin/linagliptin | 12 | 336 | £637 | -7.4% ▼ |
| Dexamethasone phosphate | 12 | 196 | £660 | +163.1% ▲ |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 12 | 319.5K | £6.9K | +12.7% ▲ |
| Other eye tear/lubricant/astringent preparations | 12 | 1,440 | £326 | +9.7% ▲ |
| Ipratropium bromide | 12 | 12 | £87 | -26.0% ▼ |
| Pilocarpine hydrochloride | 12 | 1,008 | £469 | +11.7% ▲ |
| 12 | 230 | £168 | -59.8% ▼ | |
| 12 | 720 | £178 | -37.9% ▼ | |
| 12 | 60 | £163 | +28.3% ▲ | |
| 12 | 690 | £2.1K | +10.3% ▲ | |
| Propantheline bromide | 11 | 924 | £849 | -15.3% ▼ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 11 | 308 | £44 | -68.4% ▼ |
| Valsartan with diuretic | 11 | 308 | £141 | -17.0% ▼ |
| Gemfibrozil | 11 | 616 | £372 | +8.9% ▲ |
| Desloratadine | 11 | 330 | £28 | -61.9% ▼ |
| Trihexyphenidyl hydrochloride | 11 | 1,232 | £58 | -61.2% ▼ |
| Doxycycline monohydrate | 11 | 80 | £47 | +1.3% vs avg |
| Ready to serve infant formula, high energy (0913104) | 11 | 113.4K | £1.6K | -0.4% vs avg |
| Bupivacaine hydrochloride | 11 | 11 | £47 | -77.0% ▼ |
| 11 | 44 | £279 | -13.5% ▼ | |
| 11 | 11 | £49 | +588.8% ▲ | |
| Naftidrofuryl oxalate | 10 | 840 | £98 | -69.3% ▼ |
| Daridorexant | 10 | 282 | £376 | -23.5% ▼ |
| Phased formulations of ethinylestradiol | 10 | 630 | £32 | +124.1% ▲ |
| Vardenafil | 10 | 40 | £122 | -28.4% ▼ |
| Potassium chloride | 10 | 400 | £684 | -46.5% ▼ |
| Oral rehydration salts | 10 | 78 | £35 | -65.4% ▼ |
| Menadiol sodium phosphate | 10 | 280 | £684 | +76.5% ▲ |
| 10 | 281.0K | £5.2K | +10.3% ▲ | |
| Crotamiton | 10 | 300 | £30 | -39.9% ▼ |
| Acitretin | 10 | 560 | £187 | -23.0% ▼ |
| Lidocaine | 10 | 335 | £302 | -13.0% ▼ |
| 10 | 2,800 | £126 | -50.5% ▼ | |
| 10 | 19 | £106 | -43.6% ▼ | |
| 10 | 1,000 | £141 | -74.3% ▼ | |
| 10 | 360 | £692 | -51.2% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.